Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,993,200 | 4,462,900 | 5,496,700 | 3,220,500 | 3,109,300 |
| Marketable Securities | 733,800 | 34,700 | 429,400 | 1,610,700 | 781,700 |
| Receivables | 4,158,100 | 3,831,800 | 3,277,300 | 3,704,800 | 2,694,400 |
| Inventories | 2,517,700 | 2,849,900 | 2,493,200 | 2,523,700 | 2,270,300 |
| Income taxes - deferred | N/A | N/A | 382,100 | 642,800 | 519,200 |
| TOTAL | $14,840,000 | $12,486,500 | $12,453,300 | $12,316,100 | $9,694,400 |
| Non-Current Assets | |||||
| PPE Net | 7,940,700 | 8,197,400 | 8,626,300 | 8,575,100 | 8,152,300 |
| Investments And Advances | 1,779,500 | 1,155,800 | 1,544,600 | 577,100 | 1,001,900 |
| Other Non-Current Assets | 6,441,200 | 5,621,200 | 6,588,400 | 5,406,500 | 3,106,800 |
| TOTAL | $16,161,400 | $14,974,400 | $16,759,300 | $14,558,700 | $12,261,000 |
| Total Assets | $31,001,400 | $27,460,900 | $29,212,600 | $26,874,800 | $21,955,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,072,200 | 968,100 | 885,800 | 924,400 | 789,400 |
| Other current liabilities | 4,701,200 | 4,687,900 | 5,611,600 | 3,346,700 | 2,972,800 |
| TOTAL | $6,926,900 | $6,568,100 | $13,109,700 | $5,436,800 | $5,085,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,770,500 | 6,634,700 | 4,615,700 | 4,593,500 | 3,494,400 |
| Other Non-Current Liabilities | 4,891,200 | 4,732,800 | 4,674,800 | 3,053,100 | 2,332,600 |
| TOTAL | $11,661,700 | $11,367,500 | $9,365,200 | $7,934,100 | $5,889,200 |
| Total Liabilities | $18,588,600 | $17,935,600 | $22,474,900 | $13,370,900 | $10,974,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,157,665 | 1,153,145 | 1,149,016 | 1,136,985 | 1,134,034 |
| Common Shares | 721,300 | 718,700 | 711,100 | 709,500 | 707,900 |
| Retained earnings | 12,732,600 | 9,830,400 | 7,654,900 | 11,806,700 | 10,926,700 |
| Other shareholders' equity | -5,743,600 | -5,560,400 | -5,505,900 | -2,716,500 | -4,124,800 |
| TOTAL | $12,412,800 | $9,525,300 | $6,737,700 | $13,503,900 | $10,980,700 |
| Total Liabilities And Equity | $31,001,400 | $27,460,900 | $29,212,600 | $26,874,800 | $21,955,400 |